JUDY FONG: Open Payments
NPI 1760021422 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 37 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $467 · 2025 $1,041
Food & beverage: $892Education: $149
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $173 |
| Actelion Pharmaceuticals US, Inc. | 4 | $120 |
| United Therapeutics Corporation | 5 | $114 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Regeneron Healthcare Solutions, Inc. | 2 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Insmed, Inc. | 3 | $58 |
| Grifols USA, LLC | 1 | $35 |
| Aimmune Therapeutics, Inc. | 1 | $32 |
Products named: OFEV, DUPIXENT, LIVTENCITY, OPSYNVI, Arikayce, OPSUMIT, Tyvaso, Prolastin-C Liquid.
Industry payments across AZ — which companies pay providers there.
